Research articlePublished 8 Apr 2019
Concentrates from Aframomium melegueta K. Schum and Vernonia amygdalina Delile Inhibit Proliferation of Atypical Fowl Pox Virus in Embryonated Chick Eggs (Eces)
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This study evaluated the inhibition property of concentrates from Aframomium melegueta K.Schum and Vernonia amygdalina Delile against the proliferation of atypical Fowlpox virus strain (FPV Kabete) in Embryonated chick eggs (ECEs). We determined the effect of the concentrates on the propagation of the atypical FPV in ECEs via virus inhibition assay and linked the possible mechanisms by which compounds present in the concentrates were able to reduce the levels of cytopathic effect expressions caused by the atypical FPV in ECEs. The results showed that the concentrates had multiple inhibitory effects against the FPV while they showed mild toxicities in chick embryos with toxic threshold concentration set at 300 µM. In summary, the A. melegueta concentrate had stronger inhibitory effect against the FPV proliferation; it increased the average embryo weight (from 12.56 ± 1.61 g to 23.19 ± 1.79 g) and diminished the FPV Log10EID50 titer from 3.86 to 3.08. It also reduced the mean number of pock lesions from 18.28 ± 1.84 pfu/100EID50 to 2.19 ± 0.65 pfu/100EID50 and likewise reducing the mean pock diameter from 22.48 ± 2.74 mm to 4.89 ± 1.04 mm. Comparatively, the V. amygdalina concentrate showed lesser inhibitory effect than the A. melegueta concentrate; it increased the average embryo weight (from 12.56 ± 1.61 g to 19.49 ± 1.33 g), diminished the FPV Log10EID50 titer from 3.86 to 3.34, reduced the mean number of pock lesions from 18.28 ± 1.84 pfu/100EID50 to 6.85 ± 1.77 pfu/100EID50 and likewise reducing the mean pock diameter from 22.48 ± 2.74 mm to 8.96 ± 1.26 mm. This study showed the efficacy of the concentrates to inhibit the proliferation of the FPV in ECEs and that compounds contained in the concentrate can lead the discovery for biosynthesis of novel antipoxvirus inhibitors.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Virology & Antiviral Research
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Afolami OI”
- BylineArticles whose byline prints “Oladunmoye MK”
- BylineArticles whose byline prints “Chukwuedo AA”
- BylineArticles whose byline prints “Asala OO”
- BylineArticles whose byline prints “Nwagbo IO”
- BylineArticles whose byline prints “Oladejo BO”
- BylineArticles whose byline prints “Abe TO”
- BylineArticles whose byline prints “Akpa AR”
